drugset / Trial / NCT07021547
A Study of LY3867070 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Timeline
- Start
- 2025-05-27
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3867070 | Unknown | — | Oral |
Indications
No indication recorded.